James Chopas - Aug 30, 2021 Form 4 Insider Report for Apellis Pharmaceuticals, Inc. (APLS)

Role
VP, Corporate Controller / Chief Accounting Officer
Signature
/s/ David Watson, attorney-in-fact for James Chopas
Stock symbol
APLS
Transactions as of
Aug 30, 2021
Transactions value $
$0
Form type
4
Date filed
9/1/2021, 04:34 PM
Next filing
Oct 27, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction APLS Common Stock Award $0 +7.6K $0.00 7.6K Aug 30, 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction APLS Stock Option (right to buy) Award $0 +21.8K $0.00 21.8K Aug 30, 2021 Common Stock 21.8K $65.41 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares are issuable upon vesting of restricted stock units that each represent a contingent right to receive one share of APLS common stock. The restricted stock units vest as to 25% of the shares underlying the award on the first anniversary of the grant date and as to an additional 25% of the shares underlying the award annually until the fourth anniversary of the grant date, subject to continued service.
F2 This option was granted on August 30, 2021 and vests as to 25% of the shares underlying the option on the first anniversary of the grant date and thereafter as to 1/48th of the shares underlying the option monthly until the fourth anniversary of the grant date, subject to continued service.

Remarks:

VP, Corporate Controller / Chief Accounting Officer